The Seroepidemiology of Hepatitis A and B in a Japanese Town

Sera collected from 1,118 healthy children and adults aged between four years and 90 years during the period 1989 to 1990, were tested for serological markers of hepatitis A virus (HAV) [antibody to HAV (anti-HAV)] and hepatitis B virus (HBV) [hepatitis B surface antigen (HBsAg) and antibody to hepa...

Full description

Saved in:
Bibliographic Details
Published in:Asia-Pacific journal of public health 1992-04, Vol.6 (2), p.26-29
Main Authors: Akbar, S.M. Fazle, Onji, Morikazu, Kanaoka, Mitso, Horiike, Norio, Michitaka, Kojiro, Masumoto, Toshikazu, Nonaka, Takashi, Kanda, Kimitoshi, Kajino, Kazunori, Kumamoto, Izumi, Nadano, Seijin, Ohta, Yasuyuki
Format: Article
Language:English
Subjects:
Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Child
Child, Preschool
Female
Hepatitis A - epidemiology
Hepatitis A Antibodies
Hepatitis Antibodies - blood
Hepatitis B - epidemiology
Hepatitis B Antibodies - blood
Hepatitis B Surface Antigens - blood
Hepatovirus - immunology
Humans
Japan - epidemiology
Male
Middle Aged
Seroepidemiologic Studies
Urban Population
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sera collected from 1,118 healthy children and adults aged between four years and 90 years during the period 1989 to 1990, were tested for serological markers of hepatitis A virus (HAV) [antibody to HAV (anti-HAV)] and hepatitis B virus (HBV) [hepatitis B surface antigen (HBsAg) and antibody to hepatitis B surface antigen (anti-HBsAb)]. The overall prevalence rates of anti-HAV, HBsAg, and anti-HBV were 20.2%, 0.36%, and 5.1%, respectively. No body was found to be positive for anti-HAV below 30 years of age but more than 70% of the adults aged 50 years or over were positive for anti-HAV. The level of exposure of HAV infection is declining in Japan and paradoxically at the same time a vast majority of people are becoming susceptible to more severe illness. The fall in prevalence of HBsAg possibly represents the positive impact of ongoing vaccination programs and other preventive measures against HBV.
ISSN:1010-5395
1941-2479
DOI:10.1177/101053959300600204